LAMAs were largely prescribed for patients in Turkey who had uncontrolled asthma, older age, obesity, exacerbations, and/or ...

Inhaled corticosteroids (ICS), short- and long-acting β 2-agonists (SABA and LABA), long-acting muscarinic antagonists (LAMA) and fixed-dose combinations of LABA and ICS are the cornerstones of ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

with 19% prescribed a long-acting muscarinic antagonist, 18% prescribed LAMA/LABA, 10% prescribed LAMA/LABA/ICS via a single inhaler, 3% prescribed LAMA/LABA/ICS via multiple inhalers and 1% ...

People with chronic asthma symptoms often need a once- or twice-daily inhaler to reduce the frequency and severity of asthma ...

Umeclidinium is a long-acting muscarinic antagonist, which is often referred ... Prescribe a short-acting, inhaled β 2-agonist for acute symptoms; monitor for increased need.

and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded ...